Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.

"Authors' Disclosures N.L. Crossnohere reports grants from NCI during the conduct of the study. M. Bachini reports other support from AstraZeneca, Boehringer Ingelheim, Kinnate, Taiho, Incyte; and other support from TriSalus outside the submitted work; and is a Cholangiocarcinoma Foundation employee. C.K. Blair reports grants from NCI during the conduct of the study. J.D. Carpten reports personal fees from Stand Up to Cancer Scientific Advisory Committee, BreakThrough Cancer Scientific Advisory Board; and personal fees from Roche/Genentech Advancing Inclusive Research External Advisory Board outside the submitted work; and is a member of the AACR Board of Directors. B.F. Drake reports grants from NCI during the conduct of the study. K.A. Janeway reports personal fees from Bayer; and personal fees from Illumina outside the submitted work. S.I. Mishra reports grants from NCI during the conduct of the study. E.D. Paskett reports grants from Merck Foundation, Pfizer, Genentech; and grants from Guardant Health outside the submitted work. C. Ricker reports grants from NIH/NCI during the conduct of the study. M.C. Stern reports grants from NIH during the conduct of the study. J.M. Trent reports grants from NCI during the conduct of the study. N. Wagle reports grants from NCI during the conduct of the study; personal fees and other support from Relay Therapeutics, Flare Therapeutics; personal fees from Eli Lilly; grants from AstraZeneca, Puma Biotechnology; and personal fees from Genentech outside the submitted work. J.F. Bridges reports grants from NCI during the conduct of the study. No disclosures were reported by the other authors."

"This work was supported by grants from the NCI. J Carpten and H Lenz are recipients of 1U2CCA252971–01A1; E Claus, B Kwan, and R Verhaak are recipients of 1U2CCA252979–01A1; G.A. Colditz, L. Ding, R.C. Fields, and B.F. Drake are recipients of 1U2CCA252981–01A1; N. Wagle and K.A. Janeway are recipients of 1U2CCA252974–01; C. Willman and J.M. Trent are recipients of 1U2CCA252973–01; J.F. Bridges, Q. Ma, and E.D. Paskett are recipients of 1U24CA252977–01."